COVID-19 updates, including vaccine information, for our patients and visitors Learn More

Menu
Search

Internationally Renowned UCSD Physician-Researcher Chosen as Distinguished Scientist by American Heart Association

 

December 03, 2010  |  

Michael H.Criqui, MD, MPH, FAHA, professor and chief of the Division of Preventive Medicine in the Department of Family and Preventive Medicine at the University of California, San Diego was honored as a Distinguished Scientist by the American Heart Association (AHA) at this year’s AHA Scientific Sessions in Chicago, Illinois.  This is the highest honor given by the AHA.

Michael Criqui

Dr. Michael Criqui was named 1 of 5 AHA Distinguished Scientists for 2010

In 2003, the American Heart Association created a Distinguished Scientist designation to honor AHA/ASA members who have made extraordinary contributions to cardiovascular and stroke research.   This title recognizes seminal research work that has importantly advanced the understanding and management of cardiovascular disease or stroke.

Criqui is one of five honorees this year to join the ranks of 65 other preeminent researchers and scientists.  He is an active and productive investigator in cardiovascular epidemiology and preventive cardiology, and has made seminal contributions in the fields of peripheral arterial disease, subclinical atherosclerosis and peripheral venous disease.  Criqui has published over 385 manuscripts and book chapters and has been an invited lecturer at numerous national and international meetings.

# # #

Media Contact: Kim Edwards, 619-543-6163, kedwards@ucsd.edu


Related Specialties



Media Contact

Share This Article


Related News

3/5/2021
In a study published in the March 5, 2021 online edition of Cerebral Cortex, researchers at University of California San Diego School of Medicine found that specific regions of the brain resp ...
3/3/2021
UC San Diego School of Medicine researchers develop an automated process to test city sewage for SARS-CoV-2, allowing them to forecast the region’s COVID-19 caseload one to two weeks ahead of clinical ...
3/2/2021
Researchers at UC San Diego School of Medicine and elsewhere have identified a new drug that could prevent AD by modulating, rather than inhibiting, a key enzyme involved in forming amyloid plaques.
3/2/2021
Researchers at UC San Diego Health see a possible way to detect heart disease through the eye.



Follow Us